Sex: M
Vaccine: DTAP, HEP, HIBV, OPV, DTAP, HEP, HIBV, IPV, MMR, PNC, VARCEL, DTAP, HEP, HIBV, IPV
Symptoms: Drug toxicity, Nervous system disorder
Clinical narrative: From initial information received on 15/Feb/2005 from another manufacturer (manufacturer report number WAES0410USA02892) regarding an adverse event occurring in the USA, it was reported that a male minor (specifics were not provided) received the first dose of IPOL (lot number N0726, which is not a recognized lot number) administered in the right leg, the first dose of Acel-Immune, lot number 547-788, administered in the left leg; the second dose of Engerix-B, lot number ENG2721B9, administered in the right leg, and the first dose of HIBTITITER, lot number 402203A, administered in the right leg on 16/Feb/1999. Specifics provided are as follows: Information has been received regarding a case in litigation concerning a male minor who was administered vaccines containing mercury and/or thimerosal. He has suffered devastating injuries caused by mercury toxicity through IM injection of mercury. He was exposed to highly toxic emissions from certain facilities in the environmental zone of his residence which contributed to his total mercury exposure and total dose of poisonous mercury. Emissions from mercury emitted facilities toxins include mercury, lead, chromium, and other heavy metals. Because of his heightened vulnerability to heavy metal poisoning and his compromised condition related to the mercury poisoning, he was and is unable to process heavy metals and suffered neurological compromise as a result of heavy metals contributed by medical waste burning utilities. His impaired condition is compounded by these exposures and his injuries made worse by them. It was reported that the patient was poisoned by the cumulative doses of mercury emitted by these facilities, and as a result, suffers from, and in the future will continue to suffer from, the toxic neurological effects of mercury poisoning. Follow up information received in a pediatric vaccine administration record indicated that the patient received a third dose of hepatitis B vaccine administered in the right leg on 6/30/99. Concomitant therapy on 6/30/99 included a third dose of diphtheria toxoid (+) pertussis acellular 4-component vaccine (+) tetanus toxoid (batch # 462313) in the left leg, a third dose of HIB conjugate vaccine (batch # 411003X) in the right leg, and a third dose of poliovirus vaccine live oral (0800L112) PO. Other vaccinations included: the first, second, and fourth doses of diphtheria toxoid (+) pertussis acellular 4component vaccine (+) tetanus toxoid (batch # 457788, 457794, 467011 respectively) in the left leg on 2/16/99, 4/20/99, and 3/16/00, respectively; the first, second, and fourth doses of HIB conjugate vaccine (batch # 402203A, A02203A, and 570403A, respectively) in the right leg (fourth dose administered in the left leg) on 2/16/99, 4/20/99, and 3/16/00, respectively); the first and second doses of poliovirus vaccine inactivated (batch # N0726 and O0957, respectively), in the right leg and left leg, respectively on 2/16/99 and 4/20/99, respectively; a first dose of MMR (lot # 632344/1081J) administered in the right leg on 12/17/99; a second dose of hepatitis B virus vaccine )Batch # ENG2721B9) (first dose noted as OMH) administered in the right leg on 2/16/99; a dose of Mantoux (batch # 2520-11) in the left arm on 7/10/00; a dose of varicella virus vaccine live (lot # 631524/1012J) administered in the left leg on 12/17/99; and a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine (batch # 484206) administered in the left leg on 4/4/02. Upon internal review, mercury poisoning, devastating injuries, neurological compromise, and the toxic neurological effects of mercury poisoning were considered other important medical events (OMIC).